Related Experiment Video
Updated: Nov 8, 2025

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Association of Viruses in the Development of Cardiovascular Diseases
Bisma Rauff1, Arif Malik2, Yasir A Bhatti3
1Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW Sydney, Australia.
Insights
Inflammatory cardiomyopathy, a type of cardiovascular disease (CVD), involves heart inflammation and has diverse causes like infections and toxins. This review covers myocarditis, inflammatory cardiomyopathy, and atherosclerosis, focusing on virus-associated cardiac conditions.
Area of Science:
- Cardiology
- Immunology
- Infectious Diseases
Background:
- Cardiovascular diseases (CVD), particularly inflammatory cardiomyopathy, involve myocardial inflammation with a high risk of heart dysfunction.
- Etiologies are diverse, including viral, protozoal, fungal, and bacterial infections, alongside drug toxicity and systemic autoimmune diseases.
Purpose of the Study:
- To review current evidence on the types, pathogenesis, and treatment of myocarditis, inflammatory cardiomyopathy, and atherosclerosis.
- To specifically highlight virus-associated cardiac diseases and their role in disease progression.
Main Methods:
- Comprehensive literature review of existing evidence.
- Analysis of pathogen roles, host genetics, and environmental factors in disease progression.
Main Results:
- Inflammatory cardiomyopathy presents a poor prognosis despite extensive research.
- The roles of various triggers, including viral agents (as inducers or bystanders), are still under investigation.
Conclusions:
- Understanding the complex interplay of factors in inflammatory cardiomyopathy is crucial for improving outcomes.
- Further research into virus-associated cardiac diseases may offer new therapeutic targets.
Abstract:
Cardiovascular diseases (CVD), primarily inflammatory cardiomyopathy, are characterized by the infiltration of inflammatory cells into the myocardium. It has a relatively high risk of deteriorating heart function and has heterogeneous etiologies. Inflammatory cardiomyopathy is mainly mediated by viral infections but can also be mediated by protozoa, fungal or bacterial infections. Besides that, there are a wide variety of drugs, toxic substances, and systemic immune-mediated diseases that result in the development of cardiovascular diseases (CVDs). Despite broad research, inflammatory cardiomyopathy has a poor prognosis. The roles of the pathogens, host genomic counterparts and environmental triggers in the progression of disease are still under consideration, including the role of some viruses as active inducers and others as bystanders. In this review article, we review the available evidence on the types, pathogenesis and treatment of myocarditis, inflammatory cardiomyopathy, and atherosclerosis with a particular focus on virus-associated cardiac diseases.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Viral Recombination
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiovascular Drugs: Classification based on Therapeutic Indications
Rheumatic Heart Disease I: Introduction

